Skip to main content

JIA clinical trials at UCSF
1 in progress, 0 open to eligible people

  • Adalimumab in JIA-associated Uveitis Stopping Trial

    Sorry, not yet accepting patients

    The proposed study is a stratified, block-randomized, double-masked, controlled trial to determine the feasibility of discontinuing adalimumab treatment in patients with quiescent uveitis associated with juvenile idiopathic arthritis (JIA).

    San Francisco, California and other locations

Last updated: